Adrenergic Effect on Cytokine Release After Ex Vivo Healthy Volunteers’ Whole Blood LPS Stimulation

[1]  Lirui Wang,et al.  Comparison of clinical effect of dopamine and norepinephrine in the treatment of septic shock. , 2015, Pakistan journal of pharmaceutical sciences.

[2]  V. Sanders,et al.  Neuroendocrine regulation of inflammation. , 2014, Seminars in immunology.

[3]  T. van der Poll,et al.  Host innate immune responses to sepsis , 2013, Virulence.

[4]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[5]  M. Cosentino,et al.  Adrenergic modulation of immune cells: an update , 2013, Amino Acids.

[6]  A. Groeneveld,et al.  Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity? , 2011, Inflammation.

[7]  A. Groeneveld,et al.  Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity? , 2011, Inflammation.

[8]  K. Sakamoto,et al.  The Role of the Transcription Factor CREB in Immune Function , 2010, The Journal of Immunology.

[9]  J. Vincent,et al.  Comparison of dopamine and norepinephrine in the treatment of shock. , 2010, The New England journal of medicine.

[10]  T. Lawrence.  The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[11]  D. Annane,et al.  Bench-to-bedside review: β-Adrenergic modulation in sepsis , 2009, Critical care.

[12]  J. V. Sarma,et al.  Catecholamines—Crafty Weapons in the Inflammatory Arsenal of Immune/Inflammatory Cells or Opening Pandora’s Box? , 2008, Molecular medicine.

[13]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[14]  P. H. Voort.  The incomplete puzzle of vasoactive medication in (abdominal) sepsis. , 2006 .

[15]  T. van der Poll,et al.  Dobutamine does not influence inflammatory pathways during human endotoxemia* , 2006, Critical care medicine.

[16]  T. Loop,et al.  Dobutamine Inhibits Phorbol-Myristate-Acetate-Induced Activation of Nuclear Factor-&kgr;B in Human T Lymphocytes In Vitro , 2004, Anesthesia and analgesia.

[17]  M. Pinsky.  Dysregulation of the Immune Response in Severe Sepsis , 2004, The American journal of the medical sciences.

[18]  R. Silber,et al.  Effect of catecholamines on intracellular cytokine synthesis in human monocytes. , 2004, European cytokine network.

[19]  G. Fildissis,et al.  Seasonal variation in whole blood cytokine production after LPS stimulation in normal individuals. , 2003, Cytokine.

[20]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[21]  S. Ho,et al.  Dobutamine Modulates Lipopolysaccharide-Induced Macrophage Inflammatory Protein-1&agr; and Interleukin-8 Production in Human Monocytes , 2003, Anesthesia and analgesia.

[22]  J. Cavaillon,et al.  Cytokine Cascade in Sepsis , 2003, Scandinavian journal of infectious diseases.

[23]  C. Tzao,et al.  Comparison of terbutaline and dobutamine in rats with endotoxemia. , 2002, The Chinese journal of physiology.

[24]  C. Szabó,et al.  Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a β-adrenoceptor-mediated mechanism , 2002, Journal of Neuroimmunology.

[25]  E. Bosmans,et al.  The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products , 2000, Psychiatry Research.

[26]  J. Pugin,et al.  β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway , 2000 .

[27]  C. Dinarello,et al.  Proinflammatory cytokines. , 2000, Chest.

[28]  M. Reindl,et al.  A critical comparison of frequently used methods for the analysis of tumor necrosis factor-alpha expression by human immune cells. , 2000, Journal of immunological methods.

[29]  J. Pugin,et al.  beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[30]  M. Mittlböck,et al.  Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. , 1999, Shock.

[31]  M. Wadhwa,et al.  Cytokine immunoassays: recommendations for standardisation, calibration and validation. , 1998, Journal of immunological methods.

[32]  D. Papanicolaou,et al.  The Pathophysiologic Roles of Interleukin-6 in Human Disease , 1998, Annals of Internal Medicine.

[33]  N. Mackman,et al.  Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. , 1997, Journal of immunology.

[34]  T. van der Poll,et al.  Epinephrine inhibits endotoxin-induced IL-1β production: roles of tumor necrosis factor-α and IL-10. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  S. Calvano,et al.  Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation. , 1997, American journal of physiology. Endocrinology and metabolism.

[36]  C. Dinarello,et al.  Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.

[37]  S. Calvano,et al.  Epinephrine attenuates down‐regulation of monocyte tumor necrosis factor receptors during human endotoxemia , 1997, Journal of leukocyte biology.

[38]  T. van der Poll,et al.  Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. , 1997, The American journal of physiology.

[39]  S. Calvano,et al.  Catecholamines increase monocyte TNF receptors and inhibit TNF through beta 2-adrenoreceptor activation. , 1997, The American journal of physiology.

[40]  O. Lantz,et al.  Regulation of interleukin‐10 production by β‐adrenergic agonists , 1996, European journal of immunology.

[41]  O. Lantz,et al.  Regulation of interleukin-10 production by beta-adrenergic agonists. , 1996, European Journal of Immunology.

[42]  F. Schildberg,et al.  Downregulation of proinflammatory cytokine release in whole blood from septic patients. , 1995, Blood.

[43]  T. van der Poll,et al.  Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood , 1994, Infection and immunity.

[44]  C. Hunter,et al.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. , 1992, Journal of immunology.